Role of standards and funding in accelerating the development and use of microphysiological systems

Main Article Content

Surat Parvatam , Harshita Mittal, Francesca Pistollato, Kasturi Mahadik, Lorna Ewart, Abhijit Majumder, Y. K. Gupta, Sonja Beken, Rajeshwari Adheseshan, Glyn Stacey, Vishal Gandhi, Dhiraj Kumar, Helder Constantino, Goutami Nayak, Tejaswini Ghurde, Mousumi Gupta, Alokparna Sengupta, Troy Seidle
[show affiliations]

Article Details

How to Cite
Parvatam, S. (2024) “Role of standards and funding in accelerating the development and use of microphysiological systems”, ALTEX - Alternatives to animal experimentation, 41(4), pp. 669–670. doi: 10.14573/altex.2407061.
Section
Meeting Reports
References

Bachal, K., Yadav, S., Gandhi, P. et al. (2023). Design and validation of a flowless gradient generating microfluidic device for high-throughput drug testing. Lab Chip 23, 261-271. doi:10.1039/d2lc00879c

Baudy, A. R., Otieno, M. A., Hewitt, P. et al. (2020). Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry. Lab Chip 20, 215-225. doi:10.1039/c9lc00768g

Ewart, L. and Roth, A. (2021). Opportunities and challenges with microphysiological systems: A pharma end-user perspective. Nat Rev Drug Discov 20, 327-328. doi:10.1038/d41573-020-00030-2

Ewart, L., Apostolou, A., Briggs, S. A. et al. (2022). Performance assessment and economic analysis of a human liver-chip for predictive toxicology. Commun Med 2, 154. doi:10.1038/s43856-022-00209-1

Pamies, D., Ekert, J., Zurich, M. G. et al. (2024). Recommendations on fit-for-purpose criteria to establish quality management for microphysiological systems and for monitoring their reproducibility. Stem Cell Rep 19, 604-617. doi:10.1016/j.stemcr.2024.03.009

Most read articles by the same author(s)

<< < 1 2